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underwent heart transplantation in China and the effects of these mutations on protein
location and expression levels in myocardial tissue for the sake of clarifying the
potential molecular genetics of ARVC.
Methods: (1) DNA extracted from myocardial tissue of ARVC patients who received
heart transplantation and sequenced by targeted sequencing, then veriﬁed by Sanger
sequencing. (2) Diseased tissue samples with desmosomal gene mutations studied for
desmosomal protein distribution and expression using immunohistochemistry and
western blot, respectively.
Results: We identiﬁed 2 mutations in DSG2 in 3 of 26 ARVC patients (11%), 2
mutations in PKP2 in 1 of 26 patients (3.8%) and 1 mutations in DSP in 1 of 26
patients (3.8%). The results of immunohistochemistry showed that compare to normal
control, the location of desmosomal protein in intercalated disc in mutation carriers
was similar; in contrast, the staining for DSG2 and PKP2 was decreased in those
carriers who carried DSG2 and PKP2 mutations. And the results of western blot
exhibited reduced expression level of these two proteins in mutation carriers. How-
ever, the expression level of desmoplakin in DSP mutation carriers was similar
compare to normal control.
Conclusions: Five disease-causing mutations of desmosomal genes in ARVC patients
were described in this study, two of them were the reported and three of them were
newly found. Our results implied that mutations of desmosomal genes causing ARVC
via decreasing expression levels of desmosomal proteins, and suggested a dominant-
negative effect of the mutated desmosomal proteins because they were incorporated
into the desmosomes.
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Objectives: There is convincing evidence demonstrating a close association between
cardiac cytoprotection-related proteins and atrial ﬁbrillation (AF). The aim of the
present study was to identify the underlying mechanisms via proﬁling of the
expression of cardiac cytoprotection-related proteins in the left atrial appendage
(LAA) of patients with AF.
Methods: Isobaric tag for relative and absolute quantiﬁcation-coupled 2-D liquid
chromatography-tandem mass spectrometry (iTRAQ-coupled 2-D LC-MS/MS) was
used to proﬁle the expression of in the LAA from valvular disease patients with sinus
rhythm (SR; n¼6) and AF (n¼8). Specimens were pulverised and homogenised in a
lysare buffer, then sigested by trypsin and labelled with different iTRAQ tags. The
pooled labelled peptides were analysed by liquid chromatography tandem mass
spectrometry (LC-MS/MS). Protein identiﬁcation and relative iTRAQ quantiﬁcation
were performed with the ProteinPilot Software 4.0. Protein differentially expression
were validated by Western blot analysis to verify the results obtained by iTRAQ
protomic studies.
Results: 1023 unique proteins from the cardia tissues were acquired. Among those
proteins, we identiﬁed 16 cardiac cytoprotection-related proteins, consisting of 12 heat
shock proteins, 4 peroxide enzyme related proteins. 7 proteins of them were expressed
differently in the atrial appendage of patients with AF when compared with SR pa-
tients. 4 proteins like 10 kDa heat shock protein, heat shock 70 kDa protein 1, heat
shock protein beta-1 and heat shock protein beta-7 were up-regulated, while 3 proteins
as heat shock protein HSP 90-beta, peroxiredoxin-5 and stress-70 protein were down-
regulated in LAA of AF patients. Those proteins may exert a protective effect against
AF-induced cardiac myocytes damage. Western blotting has further validated the
content of desmoplakin, cytochrome c oxidase subunit 5B and heat shock proteinb-1
in the LAA between AF and SR patients with mitral valve disase. Also, the reliability
of the iTRAQ proteomic studies was validated.
Conclusions: In summary, those up-ragulated cardiac cytoprotection-related proteins
suggested that there is a adaptative response in the LAA tissues to atrial stress and
cardiac myocytes damage induced by AF. While, the down-ragulated proteins may
demonstrated that the adaptative ability was started to impaired during the permanent
atrial ﬁbrillation. The adaptative response of the cardiac cytoprotection-related pro-
teins may be involved in the matrix of AF.
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Objectives: The aim of this study was to report the adhesion molecules impact of
short-term intensive rosuvastins in patients with acute coronary syndrome undergoing
percutaneous coronary intervention (PCI).
Methods: The study involved 96 ACS patients admitted between June 2012 and
December 2013 to our hospital, 53 cases were randomly divided into the high-dose
rosuvastins (40mg a day before PCI) and 43 to the placebo arm. Cell adhesion
molecule-1 (ICAM-1), vascular cell adhesion molecule-1 (VCAM-1) and E-selectin
plasma levels were evaluated at randomization (12h before intervention), and 6h and
24h after intervention.
Results: The plasma levels of ICAM-1, VCAM-1 and E-selectin were similar at
randomization before intervention in both groups (P>0.05). There was no obviouslyJACC Vol 64/16/Suppl C j October 16–19, 2014 j GW-ICC Abstracts/Bdifference of E-selectin plasma levels at any time-point in the two groups (P>0.05).
Signiﬁcant attenuation of ICAM-1, VCAM-1 elevation occurred at 6h and 24h in the
rosuvastins group (ICAM-1 20132 vs.25229ng/ml; P<0.05 and 29637
vs.35632 ng/ml; P<0.05; VCAM-1 52863 vs. 57368ng/ml; P<0.05 and 592
67vs. 64668ng/ml; P<0.05).
Conclusions: In patients with acute coronary syndrome undergoing percutaneous
coronary intervention, attenuation of ICAM-1, VCAM-1 elevation after intensive
rosuvastins is associated with endothelial inﬂammatory response. The mechanisms of
rosuvastins were more contribution for cardioprotection.
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Objectives: This study sought to the expression proﬁle long noncoding RNAs
(lncRNAs) in oxidized low-density lipoprotein (ox-LDL) treated human umbilical
vein endothelial cells (HUVECs) compared with normal HUVECs through microarray
analysis.
Methods: The global lncRNAs and mRNAs expression proﬁles in ox-LDL treated
HUVECs compared with normal HUVECs were analysed through the Arraystar Human
LncRNA Array v2.0. Four upregulated lncRNAs (ENST00000431378, AK094119,
ENST00000447336, chr8:49776604-49779322+) were validated by quantitative real-
time reverse transcriptase polymerase chain reaction (qRT-PCR). GO analysis and
pathway analysis were performed in the standard enrichment computation method.
Results: Approximately 141 lncRNAs and 113 mRNAs were identiﬁed to be different
expression (fold change2.0, P-value cut-off is 0.05) in ox-LDL treated HUVECs
compared with normal HUVECs. Four upregulated lncRNAs were validated by qRT-
PCR. GO analysis showed that the highest enriched GOs targeted by up-regulated
transcripts were biological regulation (ontology: biological process) and that the
highest enriched GOs targeted by the down-regulated transcripts were cellular meta-
bolic process (ontology: biological process). Pathway analysis indicated that 4 path-
ways corresponded to up-regulated transcripts and those 22 pathways corresponded to
down-regulated transcripts (P-value cut-off is 0.05).
Conclusions: Our data reveal that clusters of lncRNAs are aberrantly expressed in
ox-LDL treated HUVECs compared with normal HUVECs, which indicate that
lncRNAs differentially expressed in endothelial cells may play a partial or key role in
endothelial dysfunction and damage. This study may provide novel insights into the
mechanism and potential targets for the future treatment of atherosclerosis.
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Objectives: The proliferation of pulmonary artery smooth muscle cells (PASMCs)
contribute to the development of pulmonary vascular remodeling which will ulti-
mately lead to pulmonary hypertension. In this study, we have investigated the effect
and molecular mechanisms of hesperetin on the platelet-derived growth factor (PDGF)
-BB-induced proliferation of primary cultured rat PASMCs.
Methods: PASMCs were incubated with different concentrations of hesperetin
(12.5mM, 25mM, 50mM, 100mM) in the presence of PDGF-BB (20 ng/ml) or not. Cell
proliferation was determined by CCK-8 assay.
The toxicity of hesperetin on PASMCs was determined by the trypan blue exclusion
test. Cell cycle progression was determined using a Cell cycle and Apoptosis Analysis
Kit. The mRNA expression of cyclin D1, cyclin E, CDK2, CDK4 and p27 were
detected using Real-time PCR. The activation state of ERK1/2, P38, JNK, AKT and
GSK3b was investigated using Western Blotting.
Results: Our data demonstrated that hesperetin signiﬁcantly inhibit the proliferation
and DNA synthesis of PASMCs induced by PDGF-BB in a dose- and time-dependent
manner without cell cytotoxicity. In accordance with these ﬁndings, hesperetin
blocked progression through G0/G1 to S phase of the cell cycle. We also demonstrated
that hesperetin inhibit the cell cycle was associated with the inhibition of the mRNA
expression of cyclin D1, cyclin E, CDK2, and CDK4, as well as an increase of the
mRNA expression of p27 in PDGF-BB-stimulated PASMCs. Further studies showed
that the beneﬁcial effect of hesperetin on blocking the proliferation of PASMCs is
related to suppression of the P38 and AKT/GSK3b signaling pathway, but has little
effect on the ERK1/2 and JNK signaling pathways.
Conclusions: These results demonstrate that hesperetin suppresses PDGF-BB-induced
PASMC proliferation through the P38 and AKT/GSK3b signaling pathway and sug-
gests that it may be a feasible therapy for pulmonary vascular remodeling diseases.
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